Participants lost an average of 14.9% of their body weight over 68 weeks compared to merely 0.4% with placebo
The subcutaneous injections available in the United States are dulaglutide (Trulicity, Eli Lilly, for type 2 diabetes), liraglutide (Victoza, Novo Nordisk, for type 2 diabetes), semaglutide (Ozempic, Novo Nordisk, for type 2 diabetes and Wegovy, for weight loss), tirzepatide (Mounjaro, Eli Lilly, for type 2 diabetes), and Zepbound (Eli Lilly, for weight loss)
This may increase the general risk of inadequate micronutrient intake over time
Glutathione is a powerful antioxidant the body makes on its own
The muscle you build stays with you